No Plasmatic Proteomic Signature at Clinical Disease Onset Associated With 11 Year Clinical, Cognitive and MRI Outcomes in Relapsing-Remitting Multiple Sclerosis Patients

by Claire Bridel, Anand J. C. Eijlers, Wessel N. van Wieringen, Marleen Koel-Simmelink, Cyra E. Leurs, Menno M. Schoonheim, Joep Killestein, Charlotte E. Teunissen
Published 2018-10-01